Joan-Ramon Grífols

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

Andrea Alemany, Pere Millat-Martínez, Marc Corbacho‐Monné et al. · The Lancet Respiratory Medicine · 2022 · 85 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+cell count to guide pre-emptive or immediate rescue mobilization.

Juan‐Manuel Sancho, Mireia Morgades, Joan-Ramon Grífols et al. · Cytotherapy · 2012 · 55 citations

Medicine, Hematology, Cell Therapy +15

Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization

Isabel Sánchez‐Ortega, Sergi Querol, Maite Encuentra et al. · Bone Marrow Transplantation · 2014 · 39 citations

Medicine, Hematology, Oncology +10

Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years old

Cristina Motlló, Juan‐Manuel Sancho, Joan-Ramon Grífols et al. · Cytotherapy · 2013 · 13 citations

Medicine, Cell Biology, Hematology +14